BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23837683)

  • 1. Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor.
    Verma MK; Miki Y; Abe K; Suzuki T; Niikawa H; Suzuki S; Kondo T; Sasano H
    J Transl Med; 2013 Jul; 11():167. PubMed ID: 23837683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells.
    Sherbet DP; Guryev OL; Papari-Zareei M; Mizrachi D; Rambally S; Akbar S; Auchus RJ
    Endocrinology; 2009 Sep; 150(9):4154-62. PubMed ID: 19556422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
    Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells.
    Kruchten P; Werth R; Bey E; Oster A; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):200-6. PubMed ID: 19429452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of estrone to 17-beta-estradiol in human non-small-cell lung cancer cells in vitro.
    Drzewiecka H; Jagodzinski PP
    Biomed Pharmacother; 2012 Oct; 66(7):530-4. PubMed ID: 22705334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
    Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
    Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
    Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
    Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment.
    Miki Y; Suzuki T; Abe K; Suzuki S; Niikawa H; Iida S; Hata S; Akahira J; Mori K; Evans DB; Kondo T; Yamada-Okabe H; Sasano H
    Cancer Res; 2010 Aug; 70(16):6659-69. PubMed ID: 20710045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen inhibits cell proliferation through in situ production in human thymoma.
    Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
    Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.
    Takagi K; Miki Y; Nagasaki S; Hirakawa H; Onodera Y; Akahira J; Ishida T; Watanabe M; Kimijima I; Hayashi S; Sasano H; Suzuki T
    Endocr Relat Cancer; 2010 Jun; 17(2):415-30. PubMed ID: 20228125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.
    Nagasaki S; Suzuki T; Miki Y; Akahira J; Kitada K; Ishida T; Handa H; Ohuchi N; Sasano H
    Cancer Res; 2009 Feb; 69(4):1392-9. PubMed ID: 19190350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.
    Song D; Liu G; Luu-The V; Zhao D; Wang L; Zhang H; Xueling G; Li S; Désy L; Labrie F; Pelletier G
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):136-44. PubMed ID: 16930994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers.
    Miyoshi Y; Ando A; Shiba E; Taguchi T; Tamaki Y; Noguchi S
    Int J Cancer; 2001 Dec; 94(5):685-9. PubMed ID: 11745463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.
    Castagnetta LA; Carruba G; Traina A; Granata OM; Markus M; Pavone-Macaluso M; Blomquist CH; Adamski J
    Endocrinology; 1997 Nov; 138(11):4876-82. PubMed ID: 9348218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.